Company Filing History:
Years Active: 1996-1997
Title: Innovator Spotlight: Franziska B. Grieder
Introduction: Franziska B. Grieder is a notable inventor based in Bethesda, MD, known for her groundbreaking contributions to immunology. With two patents to her name, Grieder's work focuses on innovative methods to induce immune responses, which hold significant implications for disease prevention.
Latest Patents: Grieder's latest patents include a method of inducing an immune response with a live Venezuelan Equine virus and the discovery of novel attenuating mutations in the Venezuelan Equine Encephalitis (VEE) virus. The first patent details a method where administering a recombinant VEE virus in an effective immunogenic amount can protect a subject against certain diseases. The preferred immunogens include viral immunogens, with specific emphasis on the use of VEE 26S subgenomic promoters. The second patent emphasizes the identification of novel attenuating mutations within the VEE virus, leading to the development of infectious VEE virus transcripts and particles, along with pharmaceutical formulations.
Career Highlights: Grieder currently works at the University of North Carolina at Chapel Hill, contributing her extensive knowledge and expertise to the institution's research initiatives. Her innovative approaches to immunology and virology make her a key figure in the field.
Collaborations: Throughout her career, Grieder has collaborated with accomplished professionals such as Robert E. Johnston and Nancy L. Davis. These partnerships have enhanced her research and contributed to the successful development of her patents.
Conclusion: Franziska B. Grieder's contributions to the field of immunology through her patents play a crucial role in advancing the understanding and treatment of infectious diseases. Her work continues to inspire future innovations in the health sciences, demonstrating the impact of dedicated inventors in transforming medical research and technology.